Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qizao Oral Liquid is a traditional Chinese medicine (TCM) formulation, typically used as an oral liquid preparation. It is not a single chemical entity but rather a multi-herbal combination, commonly prescribed in China for various indications such as respiratory tract infections, cough, and symptoms associated with colds or flu. The exact herbal composition can vary by manufacturer but often includes ingredients like Astragalus membranaceus (Huangqi), Glycyrrhiza uralensis (licorice root), and other botanicals traditionally used to "tonify Qi" and relieve dryness according to TCM theory. The mechanism of action is not defined in Western pharmacological terms; instead, it is believed to modulate immune function and provide symptomatic relief through the combined effects of its herbal components. There are no well-established clinical trials published in major English-language medical databases for this specific product under the name "Qizao Oral Liquid." It should be considered a dietary supplement or traditional remedy rather than a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qizao Oral Liquid.